Vontobel Holding’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.85M Sell
50,266
-10,498
-17% -$2.04M 0.03% 268
2025
Q4
$10.5M Sell
60,764
-3,796
-6% -$691K 0.03% 282
2025
Q3
$12.3M Sell
64,560
-2,034
-3% -$361K 0.04% 244
2025
Q2
$12M Buy
66,594
+22,719
+52% +$3.95M 0.04% 239
2025
Q1
$7.42M Sell
43,875
-3,436
-7% -$564K 0.03% 260
2024
Q4
$7.14M Buy
47,311
+17,470
+59% +$2.72M 0.02% 267
2024
Q3
$4.63M Sell
29,841
-2,956
-9% -$441K 0.02% 326
2024
Q2
$4.49M Sell
32,797
-5,996
-15% -$821K 0.01% 321
2024
Q1
$5.16M Sell
38,793
-14,337
-27% -$1.86M 0.04% 311
2023
Q4
$7.33M Sell
53,130
-2,000
-4% -$263K 0.06% 243
2023
Q3
$6.72M Buy
55,130
+11,665
+27% +$1.55M 0.06% 253
2023
Q2
$6.11M Buy
43,465
+500
+1% +$68.9K 0.05% 268
2023
Q1
$6.08M Buy
42,965
+11,139
+35% +$1.59M 0.06% 265
2022
Q4
$4.98M Buy
31,826
+4,627
+17% +$665K 0.05% 279
2022
Q3
$3.39M Buy
27,199
+6,814
+33% +$897K 0.04% 316
2022
Q2
$2.81M Sell
20,385
-5,491
-21% -$748K 0.03% 339
2022
Q1
$3.6M Sell
25,876
-365
-1% -$50.9K 0.03% 325
2021
Q4
$4.5M Buy
26,241
+9,000
+52% +$1.37M 0.04% 282
2021
Q3
$2.5M Buy
17,241
+595
+4% +$87.1K 0.02% 403
2021
Q2
$2.21M Buy
16,646
+4,000
+32% +$524K 0.02% 416
2021
Q1
$1.62M Buy
12,646
+1,050
+9% +$129K 0.01% 445
2020
Q4
$1.41M Buy
+11,596
New +$1.41M 0.01% 474

Other funds holding DGX

Vontobel Holding's DGX Position: Q1 2026 in Review

Vontobel Holding reduced its Quest Diagnostics (DGX) stake by 17% in Q1 2026, selling an estimated $2.04M and leaving 50,266 shares worth $9.85M. The position accounts for 0.03% of the portfolio, ranked #268.

Vontobel Holding first reported a position in DGX in Q4 2020 and has held it in 22 quarters since. The position peaked at $12.3M in Q3 2025. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Vontobel Holding held 50,266 shares of Quest Diagnostics worth $9.85M as of Q1 2026.
  • Vontobel Holding sold 10,498 Quest Diagnostics shares in Q1 2026, an estimated $2.04M.
  • Quest Diagnostics made up 0.03% of Vontobel Holding's portfolio in Q1 2026, its #268 holding.
  • Vontobel Holding first reported a position in Quest Diagnostics in Q4 2020 and has held it in 22 quarters since.
  • Vontobel Holding's Quest Diagnostics position peaked at $12.3M in Q3 2025.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Vontobel Holding's 13F filing for Q1 2026, filed 8 May 2026.